News and Events

New study tests therapy in patients with hemorrhagic cystitis after bone marrow transplant

Jennifer A. Kanakry, M.D., Associate Research Physician in the Experimental Transplantation and Immunotherapy Branch, is leading CCR’s participation in a study of a drug, Viralym-M, that targets six viruses that can cause hemorrhagic cystitis (HC) in people who have had a hematopoietic cell transplant. Researchers are most interested in Viralym-M’s ability to clear the symptoms of HC faster than a placebo and evaluating Viralym-M’s effect on five other viruses.

Howard A. Young receives 2021 ICIS Mentorship Award

Howard A. Young, Ph.D., Senior Investigator in the Laboratory of Cancer Immunometabolism, is the first recipient of the newly established International Cytokine & Interferon Society (ICIS) Mentorship Award. This award recognizes ICIS members who have made significant and sustained contributions to the career development of trainees and to the profession through outstanding mentoring.

Clinical trial studies immunotherapy and radiation for pancreatic cancer

Fewer than 10 percent of people with pancreatic cancer can have surgery, which offers the best chance of a cure. Udo Rudloff, M.D., Ph.D., Senior Investigator in the Pediatric Oncology Branch, is leading a study testing a combination of immunotherapy and radiation for people with advanced pancreatic cancer to shrink tumors and make surgery possible.

CCR postbaccalaureate fellow awarded Fulbright to study cancer disparities in Nigeria

Anu Ajao is a CCR postbaccalaureate fellow who recently received a Fulbright Research Award to study personal care products and breast cancer risk in Nigerian women. In our Q&A, Anu discusses her fellowship experience as a mentee of Stefan Ambs, Ph.D., M.P.H., Senior Investigator in the Laboratory of Human Carcinogenesis, and the cancer health disparities research she will conduct this fall in Nigeria.

A conversation with CCR immunotherapy experts

June is Immunotherapy Awareness Month. We asked members of the Surgery Branch about their work with immunotherapy as they continue to make important advances in this growing field.

Vassiliki Saloura receives 2021 Conquer Cancer Foundation of ASCO Career Development Award

Vassiliki Saloura, M.D., Ph.D., Physician-Scientist Early Investigator in the Thoracic and GI Malignancies Branch, is a recipient of the 2021 Career Development Award from Conquer Cancer, the American Society of Clinical Oncology Foundation. This award provides research funding to clinical investigators who have received their initial faculty appointment as they work to establish an independent clinical cancer research program.

CCR fellow receives 2021 Conquer Cancer Foundation of ASCO Young Investigator Award

Nobuyuki Takahashi, M.D., an NIH Hematology Oncology fellow, is a recipient of the 2021 Young Investigator Award from Conquer Cancer, the American Society of Clinical Oncology Foundation. This award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

William Figg receives 2021 ACCP Distinguished Investigator Award

William Douglas Figg Sr., Pharm.D., Deputy Chief of the Genitourinary Malignancies Branch, received the 2021 American College of Clinical Pharmacology Distinguished Investigator Award. This award recognizes superior scientific expertise and accomplishments by a senior investigator, usually involving a distinct area of research in basic or clinical pharmacology for which the individual is internationally known.

AACR Annual Meeting - Session II

A number of CCR scientists will present their research at the AACR Annual Meeting. The virtual session II takes place May 17-21, 2021.

Schematic showing the transcription of DNA into RNA

Live-cell imaging reveals variability in RNA processing

Real-time imaging of messenger RNA synthesis from hundreds of human genes reveals surprising variability in the way cells’ splicing machinery processes these molecules.

Breadcrumb